Gujarat Themis Biosyn Ltd.
GUJTHEM
Rank in Stocks
#11827
Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the... Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the creation of pharmaceuticals and medicinal chemicals. The firm also supplies bulk drugs via a job work model within India. Its product offerings include important compounds such as Rifamycin-S, an intermediate used in treatments for tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease. Another key product, Rifamycin-O, addresses ailments like traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. Furthermore, they produce Lovastatin. Established in 1981, the company's operations are based out of Mumbai, India.
Share Price
$4.04
Last synced: 2026-11-09
Market Cap
$525.96M
Change (1 day)
0.40%
Change (1 year)
-20.52%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Gujarat Themis Biosyn Ltd. (GUJTHEM)
Category
Healthcare
EPS for Gujarat Themis Biosyn Ltd. (GUJTHEM)
EPS as of June 2026 TTM: $0.05
According to Gujarat Themis Biosyn Ltd.'s latest financial reports, its current EPS (TTM) is $0.05. At the end of 2025 the company had an EPS of $0.05, a decrease compared to its 2024 EPS of $0.07.
EPS history for Gujarat Themis Biosyn Ltd. from 2022 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.05 | -6.20% |
| 2025 | $0.05 | -19.51% |
| 2024 | $0.07 | 0.62% |
| 2023 | $0.06 | 22.77% |
| 2022 | $0.05 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 13,762.26% |
DE
|
|
| $6.08 | 12,858.64% |
DE
|
|
| $1.55 | 3,206.18% |
JP
|
|
| $3.66 | 7,703.84% |
CH
|
|
| $0.45 | 859.49% |
IL
|
Questions about Gujarat Themis Biosyn Ltd.'s earnings per share (EPS)
What is Gujarat Themis Biosyn Ltd.'s earnings per share (EPS)?
Gujarat Themis Biosyn Ltd.'s earnings per share (EPS) over the last twelve months is $0.05, as of Jun 2026.
What was Gujarat Themis Biosyn Ltd.'s earnings per share (EPS) in 2025?
In 2025, Gujarat Themis Biosyn Ltd.'s earnings per share (EPS) was $0.05, 28.57% less than in 2024 ($0.07).
How has Gujarat Themis Biosyn Ltd.'s earnings per share (EPS) changed since 2022?
From 2022 to 2025, Gujarat Themis Biosyn Ltd.'s earnings per share (EPS) went from $0.05 to $0.05, an average growth of 0.00% a year.
How does Gujarat Themis Biosyn Ltd.'s earnings per share (EPS) compare with similar companies?
Gujarat Themis Biosyn Ltd.'s earnings per share (EPS) ($0.05) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.